CompagOs AG

Personalized diagnostics for bone health

Swiss Startup - CompagOs Additional Image

CompagOs, a Swiss spin-off from ETH Zürich, is advancing bone health by helping doctors to match the right patients with the right treatments and by helping researchers to translate research findings into clinical applications. Employing innovative 3D printing technology, we produce reliable and reproducible bone organoids, called Bon3OID™, that are mineralized and multicellular. Our goal is to drive advancements in the field of drug discovery, preclinical patient stratification, predictive diagnostics and personalized medicine. We are developing and offering Bon3OID™ based products and services in the following areas:
-Healthy bone
- Fracture
- Bone metastasis
- Osteosarcoma
- Osteogenesis imperfecta
- Osteoporosis

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

29.06.2023

CompagOs wins CHF 150,000 to advance personalized medicine for bone cancer (venturekick.ch)

Last Tweets

Tweets by TwitterDev

31.05.2023

Finalized incorporation team

04.05.2023

Finalist at ETH Boost

01.04.2023

Completed 3 pilot projects for cancer in bone prototype organoid

No Jobs

No videos and documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (150'000) 2023

Website